Novel Topical Treatment for Molluscum Under Review at FDA Novel Topical Treatment for Molluscum Under Review at FDA

The active ingredient in berdazimer gel, 10.3%, is berdazimer sodium, a nitric oxide –releasing agent.MDedge News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Dermatology News Source Type: news
More News: Dermatology | Skin | Sodium